# Official Journal C 174/2007

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 174 |
| | |
| English edition | Information and Notices | Volume 5027 July 2007 |

ISSN 1725-2423

Official Journal

of the European Union

C 174

English edition

Information and Notices

Volume 5027 July 2007

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2007/C 174/01 | Non-opposition to a notified concentration (Case COMP/M.4634 — Sabanci/Verbund/Enerjisa JV) (
  1
  ) | 1 |
| 2007/C 174/02 | Non-opposition to a notified concentration (Case COMP/M.4657 — Salzgitter/KW/RSE) (
  1
  ) | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2007/C 174/01

Non-opposition to a notified concentration (Case COMP/M.4634 — Sabanci/Verbund/Enerjisa JV) (
  1
  )

1

1

2007/C 174/02

Non-opposition to a notified concentration (Case COMP/M.4657 — Salzgitter/KW/RSE) (
  1
  )

1

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2007/C 174/03 | Euro exchange rates | 2 |
| 2007/C 174/04 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  ) | 3 |
| 2007/C 174/05 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  ) | 10 |
| | NOTICES FROM MEMBER STATES |
| 2007/C 174/06 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  ) | 17 |
| 2007/C 174/07 | Amendment by France of public service obligations in respect of scheduled air services between Le Puy-en-Velay and Paris (Orly) (
  1
  ) | 27 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2007/C 174/03

Euro exchange rates

2

2007/C 174/04

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

)

3

2007/C 174/05

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

)

10

NOTICES FROM MEMBER STATES

2007/C 174/06

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises (
  1
  )

1

17

2007/C 174/07

Amendment by France of public service obligations in respect of scheduled air services between Le Puy-en-Velay and Paris (Orly) (
  1
  )

1

27

| | V   Announcements |
| --- | --- |
| | ADMINISTRATIVE PROCEDURES |
| | European Food Safety Authority |
| 2007/C 174/08 | Call for expressions of interest for the position of member of the Management Board of the European Food Safety Authority | 28 |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY |
| | Commission |
| 2007/C 174/09 | Prior notification of a concentration (Case COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N) — Candidate case for simplified procedure (
  1
  ) | 37 |
| 2007/C 174/10 | Prior notification of a concentration (Case COMP/M.4830 — CVC/Samsonite) — Candidate case for simplified procedure (
  1
  ) | 38 |
| 2007/C 174/11 | Prior notification of a concentration (Case COMP/M.4744 — INEOS/Borealis) (
  1
  ) | 39 |
| 2007/C 174/12 | Prior notification of a concentration (Case COMP/M.4734 — INEOS/Kerling) (
  1
  ) | 40 |

V   Announcements

ADMINISTRATIVE PROCEDURES

European Food Safety Authority

2007/C 174/08

Call for expressions of interest for the position of member of the Management Board of the European Food Safety Authority

28

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY

Commission

2007/C 174/09

Prior notification of a concentration (Case COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N) — Candidate case for simplified procedure (
  1
  )

1

37

2007/C 174/10

Prior notification of a concentration (Case COMP/M.4830 — CVC/Samsonite) — Candidate case for simplified procedure (
  1
  )

1

38

2007/C 174/11

Prior notification of a concentration (Case COMP/M.4744 — INEOS/Borealis) (
  1
  )

1

39

2007/C 174/12

Prior notification of a concentration (Case COMP/M.4734 — INEOS/Kerling) (
  1
  )

1

40

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 27.7.2007 | EN | Official Journal of the European Union | C 174/1 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/1

---

Non-opposition to a notified concentration

(Case COMP/M.4634 — Sabanci/Verbund/Enerjisa JV)

(Text with EEA relevance)

(2007/C 174/01)

On 30 May 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32007M4634. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32007M4634. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu)

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/1 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/1

---

Non-opposition to a notified concentration

(Case COMP/M.4657 — Salzgitter/KW/RSE)

(Text with EEA relevance)

(2007/C 174/02)

On 25 June 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in German and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32007M4657. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32007M4657. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu)

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 27.7.2007 | EN | Official Journal of the European Union | C 174/2 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/2

---

Euro exchange rates (1)

26 July 2007

(2007/C 174/03)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3722 |
| JPY | Japanese yen | 164,52 |
| DKK | Danish krone | 7,4413 |
| GBP | Pound sterling | 0,67080 |
| SEK | Swedish krona | 9,2266 |
| CHF | Swiss franc | 1,6607 |
| ISK | Iceland króna | 82,79 |
| NOK | Norwegian krone | 7,9760 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5842 |
| CZK | Czech koruna | 28,124 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 249,04 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6969 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 3,8060 |
| RON | Romanian leu | 3,1436 |
| SKK | Slovak koruna | 33,353 |
| TRY | Turkish lira | 1,7518 |
| AUD | Australian dollar | 1,5561 |
| CAD | Canadian dollar | 1,4396 |
| HKD | Hong Kong dollar | 10,7372 |
| NZD | New Zealand dollar | 1,7262 |
| SGD | Singapore dollar | 2,0790 |
| KRW | South Korean won | 1 260,02 |
| ZAR | South African rand | 9,5685 |
| CNY | Chinese yuan renminbi | 10,3814 |
| HRK | Croatian kuna | 7,2905 |
| IDR | Indonesian rupiah | 12 539,16 |
| MYR | Malaysian ringgit | 4,7190 |
| PHP | Philippine peso | 62,174 |
| RUB | Russian rouble | 34,9750 |
| THB | Thai baht | 40,651 |

Currency

Exchange rate

USD

US dollar

1,3722

JPY

Japanese yen

164,52

DKK

Danish krone

7,4413

GBP

Pound sterling

0,67080

SEK

Swedish krona

9,2266

CHF

Swiss franc

1,6607

ISK

Iceland króna

82,79

NOK

Norwegian krone

7,9760

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5842

CZK

Czech koruna

28,124

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

249,04

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6969

MTL

Maltese lira

0,4293

PLN

Polish zloty

3,8060

RON

Romanian leu

3,1436

SKK

Slovak koruna

33,353

TRY

Turkish lira

1,7518

AUD

Australian dollar

1,5561

CAD

Canadian dollar

1,4396

HKD

Hong Kong dollar

10,7372

NZD

New Zealand dollar

1,7262

SGD

Singapore dollar

2,0790

KRW

South Korean won

1 260,02

ZAR

South African rand

9,5685

CNY

Chinese yuan renminbi

10,3814

HRK

Croatian kuna

7,2905

IDR

Indonesian rupiah

12 539,16

MYR

Malaysian ringgit

4,7190

PHP

Philippine peso

62,174

RUB

Russian rouble

34,9750

THB

Thai baht

40,651

---

(1)

Source: reference exchange rate published by the ECB.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/3 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/3

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

(2007/C 174/04)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1.6.2007 | Optaflu | Influenza vaccine (surface antigen, inactivated, prepared in cell culture) | Novartis Vaccines and Diagnostics GmbH & Co. KG |
| Emil-von-Behring-Straße 76 |
| D-35041 Marburg |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

1.6.2007

Optaflu

Influenza vaccine (surface antigen, inactivated, prepared in cell culture)

Novartis Vaccines and Diagnostics GmbH & Co. KG

Emil-von-Behring-Straße 76

D-35041 Marburg

EU/1/07/394/001-006

Suspension for injection in pre-filled syringe

J07BB02

5.6.2007

14.6.2007

Revlimid

Lenalidomide

| Celgene Europe Limited |
| --- |
| 8 The Square |
| Stockley Park |
| Uxbridge UB11 1FW |
| Middlesex |
| United Kingdom |

Celgene Europe Limited

8 The Square

Stockley Park

Uxbridge UB11 1FW

Middlesex

United Kingdom

EU/1/07/391/001-004

Hard capsule

L04AX04

19.6.2007

20.6.2007

Soliris

Eculizumab

| Alexion Europe SAS |
| --- |
| 54-56, Avenue Hoche |
| F-75008 Paris |

Alexion Europe SAS

54-56, Avenue Hoche

F-75008 Paris

EU/1/07/393/001

Concentrate for solution for infusion

Non applicable

22.6.2007

25.6.2007

Invega

Paliperidone

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/07/395/001-064

Prolonged release tablet

5N05AX13

27.6.2007

25.6.2007

Pergoveris

Follitropin alfa/lutropin alfa

| Serono Europe Limited |
| --- |
| 56, Marsh Wall |
| London E14 9TP |
| United Kingdom |

Serono Europe Limited

56, Marsh Wall

London E14 9TP

United Kingdom

EU/1/07/396/001-003

Powder and solvent for solution for injection

G03GA05/G03GA07

27.6.2007

29.6.2007

Circadin

Melatonin

| Neurim Pharmaceuticals EEC Limited |
| --- |
| 6 Fortuna Court |
| Calleva Park |
| Aldermaston |
| Berkshire RG7 8UB |
| United Kingdom |

Neurim Pharmaceuticals EEC Limited

6 Fortuna Court

Calleva Park

Aldermaston

Berkshire RG7 8UB

United Kingdom

EU/1/07/392/001

Prolonged-release tablet

N05CM17

5.7.2007

29.6.2007

Siklos

Hydroxycarbamide

| Addmedica |
| --- |
| 84, rue d'Amsterdam |
| F-75009 Paris |

Addmedica

84, rue d'Amsterdam

F-75009 Paris

EU/1/07/397/001

Film-coated tablet

L01XX05

5.7.2007

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 1.6.2007 | Renagel | Genzyme Europe B.V. |
| Gooimeer 10 |
| 1411 DD Naarden |
| Nederland |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

1.6.2007

Renagel

Genzyme Europe B.V.

Gooimeer 10

1411 DD Naarden

Nederland

EU/1/99/123/001-012

5.6.2007

1.6.2007

Rebetol

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/99/107/001-005

5.6.2007

4.6.2007

Myocet

| Zeneus Pharma Limited |
| --- |
| The Magdalen Centre |
| Oxford Science Park |
| Oxford OX4 4GA |
| United Kingdom |

Zeneus Pharma Limited

The Magdalen Centre

Oxford Science Park

Oxford OX4 4GA

United Kingdom

EU/1/00/141/001

7.6.2007

| Cephalon Europe |
| --- |
| 5, Rue Charles Martigny |
| F-94700 Maisons Alfort |

Cephalon Europe

5, Rue Charles Martigny

F-94700 Maisons Alfort

6.6.2007

4.6.2007

Vasovist

| Bayer Schering Pharma AG |
| --- |
| Müllerstraße 170-178 |
| D-13342 Berlin |

Bayer Schering Pharma AG

Müllerstraße 170-178

D-13342 Berlin

EU/1/05/313/001-009

6.6.2007

4.6.2007

Aptivus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/05/315/001

6.6.2007

4.6.2007

Humira

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/256/001-010

6.6.2007

4.6.2007

Trudexa

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/257/001-010

6.6.2007

4.6.2007

Orgalutran

| N.V. Organon |
| --- |
| P.O. Box 20 |
| Kloosterstraat 6 |
| 5340 BH Oss |
| Nederland |

N.V. Organon

P.O. Box 20

Kloosterstraat 6

5340 BH Oss

Nederland

EU/1/00/130/001-002

6.6.2007

4.6.2007

TRIZIVIR

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/00/156/002-003

6.6.2007

4.6.2007

Zometa

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/01/176/001-006

6.6.2007

4.6.2007

Avandamet

| SmithKline Beecham plc |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

SmithKline Beecham plc

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

EU/1/03/258/001-022

6.6.2007

5.6.2007

Azomyr

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/00/157/001-067

7.6.2007

5.6.2007

Aerius

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/00/160/001-069

8.6.2007

5.6.2007

Neoclarityn

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/00/161/001-067

7.6.2007

5.6.2007

Abilify

| Otsuka Pharmaceutical Europe Ltd |
| --- |
| Hunton House |
| Highbridge Business Park |
| Oxford Road |
| Uxbridge |
| Middlesex UB8 1HU |
| United Kingdom |

Otsuka Pharmaceutical Europe Ltd

Hunton House

Highbridge Business Park

Oxford Road

Uxbridge

Middlesex UB8 1HU

United Kingdom

EU/1/04/276/001-020

EU/1/04/276/024-036

7.6.2007

5.6.2007

Trisenox

| Cephalon UK Ltd |
| --- |
| 20 Alan Turing Road |
| Surrey Research Park |
| Guildford |
| Surrey GU2 7YF |
| United Kingdom |

Cephalon UK Ltd

20 Alan Turing Road

Surrey Research Park

Guildford

Surrey GU2 7YF

United Kingdom

EU/1/02/204/001

8.6.2007

| Cephalon Europe |
| --- |
| 5, Rue Charles Martigny |
| F-94700 Maisons Alfort, Cedex |

Cephalon Europe

5, Rue Charles Martigny

F-94700 Maisons Alfort, Cedex

7.6.2007

5.6.2007

Visudyne

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/00/140/001

7.6.2007

7.6.2007

Tracleer

| Actelion Registration Ltd |
| --- |
| BSI Building 13th Floor |
| 389 Chiswick High Road |
| London W4 4AL |
| United Kingdom |

Actelion Registration Ltd

BSI Building 13th Floor

389 Chiswick High Road

London W4 4AL

United Kingdom

EU/1/02/220/001-005

11.6.2007

8.6.2007

Levemir

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/04/278/001-009

12.6.2007

8.6.2007

Vistide

| Pfizer Enterprises SARL |
| --- |
| 51, Avenue Kennedy-Rond Point du Kirchberg |
| L-1855 Luxembourg |

Pfizer Enterprises SARL

51, Avenue Kennedy-Rond Point du Kirchberg

L-1855 Luxembourg

EU/1/97/037/001

12.6.2007

13.6.2007

ViraferonPeg

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/00/132/001-050

15.6.2007

13.6.2007

Azopt

| Alcon Laboratories (UK) Ltd |
| --- |
| Pentagon Park |
| Boundary Way |
| Hemel Hempstead |
| Herts HP2 7UD |
| United Kingdom |

Alcon Laboratories (UK) Ltd

Pentagon Park

Boundary Way

Hemel Hempstead

Herts HP2 7UD

United Kingdom

EU/1/00/129/001-003

15.6.2007

13.6.2007

Tracleer

| Actelion Registration Ltd |
| --- |
| BSI Building 13th Floor |
| 389 Chiswick High Road |
| London W4 4AL |
| United Kingdom |

Actelion Registration Ltd

BSI Building 13th Floor

389 Chiswick High Road

London W4 4AL

United Kingdom

EU/1/02/220/001-005

15.6.2007

13.6.2007

Gardasil

| Sanofi Pasteur MSD, SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/357/001-017

15.6.2007

13.6.2007

Ebixa

| H. Lundbeck A/S |
| --- |
| Ottiliavej 9 |
| DK-2500 Valby |

H. Lundbeck A/S

Ottiliavej 9

DK-2500 Valby

EU/1/02/219/001-015

15.6.2007

13.6.2007

PegIntron

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/00/131/001-050

15.6.2007

13.6.2007

Silgard

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/06/358/001-017

15.6.2007

14.6.2007

Rapilysin

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/96/018/001

19.6.2007

19.6.2007

Zyprexa Velotab

| Eli Lilly Nederland BV |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland BV

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/99/125/001-016

21.6.2007

20.6.2007

Axura

| Merz Pharmaceuticals GmbH |
| --- |
| Eckenheimer Landstr. 100-104 |
| D-60318 Frankfurt/Main |

Merz Pharmaceuticals GmbH

Eckenheimer Landstr. 100-104

D-60318 Frankfurt/Main

EU/1/02/218/001-011

25.6.2007

20.6.2007

Cialis

| Lilly ICOS Limited |
| --- |
| St Bride's House |
| 10 Salisbury Square |
| London EC4Y 8EH |
| United Kingdom |

Lilly ICOS Limited

St Bride's House

10 Salisbury Square

London EC4Y 8EH

United Kingdom

EU/1/02/237/001-008

21.6.2007

21.6.2007

Levemir

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/04/278/001-009

25.6.2007

21.6.2007

PEGASYS

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/02/221/001-010

25.6.2007

21.6.2007

Hycamtin

| SmithKline Beecham plc |
| --- |
| 980 Great West Road |
| Brentford |
| Middlesex TW8 9GS |
| United Kingdom |

SmithKline Beecham plc

980 Great West Road

Brentford

Middlesex TW8 9GS

United Kingdom

EU/1/96/027/001

EU/1/96/027/003-005

25.6.2007

21.6.2007

Iscover

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UD8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UD8 1DH

United Kingdom

EU/1/98/070/001a-001b

EU/1/98/070/002a-002b

EU/1/98/070/003a-003b

EU/1/98/070/004a-004b

EU/1/98/070/005a-005b

EU/1/98/070/006a-006b

EU/1/98/070/007a-007b

25.6.2007

21.6.2007

Synagis

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/99/117/001-002

25.6.2007

21.6.2007

Forsteo

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/03/247/001-002

25.6.2007

21.6.2007

Revasc

| Canyon Pharmaceuticals Ltd |
| --- |
| 20-22 Bedford Row |
| London WC1R 4JS |
| United Kingdom |

Canyon Pharmaceuticals Ltd

20-22 Bedford Row

London WC1R 4JS

United Kingdom

EU/1/97/043/001-003

25.6.2007

21.6.2007

Cystagon

| Orphan Europe S.à r.l. |
| --- |
| Immeuble «Le Guillaumet» |
| F-92046 Paris La Défense |

Orphan Europe S.à r.l.

Immeuble «Le Guillaumet»

F-92046 Paris La Défense

EU/1/97/039/001-004

25.6.2007

21.6.2007

PEGASYS

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/02/221/001-010

25.6.2007

22.6.2007

Plavix

| Sanofi Pharma Bristol-Myers Squibb SNC |
| --- |
| 174, avenue de France |
| F-75013 Paris |

Sanofi Pharma Bristol-Myers Squibb SNC

174, avenue de France

F-75013 Paris

EU/1/98/069/001a-001b

EU/1/98/069/002a-002b

EU/1/98/069/003a-003b

EU/1/98/069/004a-004b

EU/1/98/069/005a-005b

EU/1/98/069/006a-006b

EU/1/98/069/007a-007b

26.6.2007

25.6.2007

M-M-RVAXPRO

| Sanofi Pasteur MSD, SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/337/001-013

27.6.2007

25.6.2007

NeoRecormon

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/97/031/001-003

EU/1/97/031/019-046

27.6.2007

27.6.2007

Vaniqa

| Shire Pharmaceutical Contracts Ltd |
| --- |
| Hampshire International Business Park |
| Chineham |
| Basingstoke |
| Hampshire RG24 8EP |
| United Kingdom |

Shire Pharmaceutical Contracts Ltd

Hampshire International Business Park

Chineham

Basingstoke

Hampshire RG24 8EP

United Kingdom

EU/1/01/173/001-003

29.6.2007

29.6.2007

Tamiflu

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/02/222/001-002

3.7.2007

29.6.2007

Ferriprox

| Apotex Europe Ltd |
| --- |
| Rowan House |
| 41 London Street |
| Reading |
| Berkshire RG1 4PS |
| United Kingdom |

Apotex Europe Ltd

Rowan House

41 London Street

Reading

Berkshire RG1 4PS

United Kingdom

EU/1/99/108/001

3.7.2007

| Apotex Europe B.V. |
| --- |
| Darwingweg 20 |
| 2333 CR Leiden |
| Nederland |

Apotex Europe B.V.

Darwingweg 20

2333 CR Leiden

Nederland

3.7.2007

29.6.2007

Humira

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/256/001-010

5.7.2007

29.6.2007

Viramune

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/97/055/001-003

5.7.2007

29.6.2007

Trudexa

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/257/001-010

5.7.2007

29.6.2007

Prandin

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/00/162/003-006

EU/1/00/162/009-012

EU/1/00/162/015-021

5.7.2007

29.6.2007

NovoNorm

| Novo Nordisk A/S |
| --- |
| Novo Allé |
| DK-2880 Bagsværd |

Novo Nordisk A/S

Novo Allé

DK-2880 Bagsværd

EU/1/98/076/004-007

EU/1/98/076/011-014

EU/1/98/076/018-024

5.7.2007

29.6.2007

Tygacil

| Wyeth Europa Ltd |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Ltd

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/06/336/001

5.7.2007

29.6.2007

Lyrica

| Pfizer Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT 13 9NJ |
| United Kingdom |

Pfizer Ltd

Ramsgate Road

Sandwich

Kent CT 13 9NJ

United Kingdom

EU/1/04/279/001-035

5.7.2007

—   Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20.6.2007 | PRILACTONE | Spironolactone | CEVA SANTE ANIMALE |
| Z.I. la Ballastière |
| F-33500 Libourne |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

20.6.2007

PRILACTONE

Spironolactone

CEVA SANTE ANIMALE

Z.I. la Ballastière

F-33500 Libourne

EU/2/07/074/001-006

Tablet

QC03DA01

22.6.2007

21.6.2007

Circovac

Inactivated porcine circovirus type 2

| MERIAL |
| --- |
| 29, avenue Tony Garnier |
| F-69007 Lyon |

MERIAL

29, avenue Tony Garnier

F-69007 Lyon

EU/2/07/075/001-004

Emulsion and suspension for emulsion for injection

QI09AA07

25.6.2007

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 14.6.2007 | Vaxxitek HVT+ IBD | Merial |
| 29, Avenue Tony Garnier |
| F-69007 Lyon |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

14.6.2007

Vaxxitek HVT+ IBD

Merial

29, Avenue Tony Garnier

F-69007 Lyon

EU/2/02/032/001

19.6.2007

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 7, Westferry Circus |
| Canary Wharf |
| London E14 4HB |
| United Kingdom |

The European Medicines Agency

7, Westferry Circus

Canary Wharf

London E14 4HB

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/10 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/10

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2007 to 30 June 2007

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

(2007/C 174/05)

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 7.6.2007 | Tracleer | Actelion Registration Ltd |
| BSI Building 13th Floor |
| 389 Chiswick High Road |
| London W4 4AL |
| United Kingdom |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

7.6.2007

Tracleer

Actelion Registration Ltd

BSI Building 13th Floor

389 Chiswick High Road

London W4 4AL

United Kingdom

This Decision is addressed to the Member States

8.6.2007

14.6.2007

Revlimid

| Celgene Europe Limited |
| --- |
| 8 The Square |
| Stockley Park |
| Uxbridge |
| Middlesex UB11 1FW |
| United Kingdom |

Celgene Europe Limited

8 The Square

Stockley Park

Uxbridge

Middlesex UB11 1FW

United Kingdom

This Decision is addressed to the Member States

18.6.2007

14.6.2007

Mifegyne

See Annex I

See Annex I

18.6.2007

20.6.2007

Soliris

| Alexion Europe SAS |
| --- |
| 54-56, Avenue Hoche |
| F-75008 Paris |

Alexion Europe SAS

54-56, Avenue Hoche

F-75008 Paris

This Decision is addressed to the Member States

21.6.2007

29.6.2007

Bovilis BVD

See Annex II

See Annex II

2.7.2007

29.6.2007

Siklos

| Addmedica |
| --- |
| 84, rue d'Amsterdam |
| F-75009 Paris |

Addmedica

84, rue d'Amsterdam

F-75009 Paris

This Decision is addressed to the Member States

3.7.2007

—   Suspension of a national marketing authorization

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 13.6.2007 | Suramox 15 % LA et Stabox 15 % LA | See Annex III | See Annex III | 14.6.2007 |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

13.6.2007

Suramox 15 % LA et Stabox 15 % LA

See Annex III

See Annex III

14.6.2007

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX I

LIST OF THE INVENTED NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCTS, ROUTE OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Invented name | Strength | Pharmaceutical form | Route of administration |
| --- | --- | --- | --- | --- | --- |
| Austria | Exelgyn |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Member State

Marketing Authorisation Holder

Invented name

Strength

Pharmaceutical form

Route of administration

Austria

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Belgium

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Denmark

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Estonia

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Finland

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

France

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Germany

| Contragest GmbH |
| --- |
| Pharmavertrieb |
| Kelsterbacher Str. 28 |
| D-64546 Walldorf-Mörfelden |

Contragest GmbH

Pharmavertrieb

Kelsterbacher Str. 28

D-64546 Walldorf-Mörfelden

Mifegyne

200 mg

Tablet

Oral use

Greece

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Latvia

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Luxembourg

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Norway

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Spain

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

Sweden

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

The Netherlands

| Bipharma B.V. |
| --- |
| Postbus 151 |
| 1380 AD Weesp |
| Nederland |

Bipharma B.V.

Postbus 151

1380 AD Weesp

Nederland

Mifegyne

200 mg

Tablet

Oral use

UK

| Exelgyn |
| --- |
| 216, Boulevard St Germain |
| F-75 007 Paris |

Exelgyn

216, Boulevard St Germain

F-75 007 Paris

Mifegyne

200 mg

Tablet

Oral use

---

ANNEX II

NAME, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ANIMAL SPECIES, ROUTES OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDER

| Member State | Applicant or Marketing Authorisation Holder | Product invented name | Pharmaceutical form | Strength | Animal species | Frequency and route of administration | Recommended dose |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Austria | Intervet Deutschland GmbH |
| Feldstrasse 1a |
| D-85716 Unterschleissheim |
| Tel. (49-89) 310 062 59 |
| Fax (49-89) 310 03 27 |

Member State

Applicant or Marketing Authorisation Holder

Product invented name

Pharmaceutical form

Strength

Animal species

Frequency and route of administration

Recommended dose

Austria

Intervet Deutschland GmbH

Feldstrasse 1a

D-85716 Unterschleissheim

Tel. (49-89) 310 062 59

Fax (49-89) 310 03 27

Bovilis BVD-MD

Suspension for injection

Per 2 ml dose:

50 ELISA units, inducing ≥ 4,6 log2 VN units

Cattle

Intramuscular injection

(Immunisation schedules are given in the product information.)

One dose = 2 ml

Belgium

| Intervet Belgium |
| --- |
| Bedrijvenlaan 7 |
| B-2800 Mechelen |
| Tel. (32-15) 43 67 28 |
| Fax (32-15) 43 67 33 |

Intervet Belgium

Bedrijvenlaan 7

B-2800 Mechelen

Tel. (32-15) 43 67 28

Fax (32-15) 43 67 33

Bovilis BVD

As above

As above

As above

As above

As above

Bulgaria

| Intervet Bulgaria EOOD |
| --- |
| 7, Iskarsko shose blvd |
| BG-1528 Sofia |
| Tel. (359-2) 970 10 70 |
| Fax (359-2) 971 09 00 |

Intervet Bulgaria EOOD

7, Iskarsko shose blvd

BG-1528 Sofia

Tel. (359-2) 970 10 70

Fax (359-2) 971 09 00

Bovilis BVD

As above

As above

As above

As above

As above

Cyprus

| Medivet Suppliers Ltd |
| --- |
| 87c Aglandjias Avenue |
| PO Box 20932 |
| CY-1665 Nicosia |
| Tel. (357) 22 33 66 05 |
| Fax (357) 22 33 66 07 |

Medivet Suppliers Ltd

87c Aglandjias Avenue

PO Box 20932

CY-1665 Nicosia

Tel. (357) 22 33 66 05

Fax (357) 22 33 66 07

Bovilis BVD

As above

As above

As above

As above

As above

Czech Republic

| Intervet s.r.o. |
| --- |
| Zlicin Business Centre |
| Na Radosti 413 |
| CZ-155 21 Prague 5 |
| Tel. (420-2) 33 34 40 25 |
| Fax (420-2) 33 34 40 22 |

Intervet s.r.o.

Zlicin Business Centre

Na Radosti 413

CZ-155 21 Prague 5

Tel. (420-2) 33 34 40 25

Fax (420-2) 33 34 40 22

Bovilis BVD

As above

As above

As above

As above

As above

Denmark

| Intervet Danmark AS |
| --- |
| PO Box 66 |
| Literbuen 9 |
| DK-2740 Skovlunde |
| Tel. (45-44) 54 69 00 |
| Fax (45-44) 53 19 55 |

Intervet Danmark AS

PO Box 66

Literbuen 9

DK-2740 Skovlunde

Tel. (45-44) 54 69 00

Fax (45-44) 53 19 55

Bovilis BVD

As above

As above

As above

As above

As above

Estonia

| Intervet Baltic States |
| --- |
| Vasario 16-osios 9-6A |
| LT-Kaunas 3000 |
| Tel. (370) 37 32 16 60 |
| Fax (370) 37 20 12 93 |

Intervet Baltic States

Vasario 16-osios 9-6A

LT-Kaunas 3000

Tel. (370) 37 32 16 60

Fax (370) 37 20 12 93

Bovilis BVD

As above

As above

As above

As above

As above

France

| Intervet S.A. |
| --- |
| Rue Olivier de Serres |
| Angers Technopole |
| BP 17144 |
| F-49071 Beaucouzé Cedex |
| Tel. (33-2) 41 22 83 83 |
| Fax (33-2) 41 22 83 00 |

Intervet S.A.

Rue Olivier de Serres

Angers Technopole

BP 17144

F-49071 Beaucouzé Cedex

Tel. (33-2) 41 22 83 83

Fax (33-2) 41 22 83 00

Bovilis BVD

As above

As above

As above

As above

As above

Germany

| Intervet Deutschland GmbH |
| --- |
| Feldstrasse 1a |
| D-85716 Unterschleissheim |
| Tel. (49-89) 310 062 59 |
| Fax (49-89) 310 03 27 |

Intervet Deutschland GmbH

Feldstrasse 1a

D-85716 Unterschleissheim

Tel. (49-89) 310 062 59

Fax (49-89) 310 03 27

Bovilis BVD-MD

As above

As above

As above

As above

As above

Greece

| Intervet Hellas S.A. |
| --- |
| 3, Paparigopoulou Street |
| GR-152 32 Halandri Athens |
| Tel. (30-210) 689 04 11 |
| Fax (30-210) 683 25 23 |

Intervet Hellas S.A.

3, Paparigopoulou Street

GR-152 32 Halandri Athens

Tel. (30-210) 689 04 11

Fax (30-210) 683 25 23

Bovilis BVD

As above

As above

As above

As above

As above

Hungary

| Intervet Hungaria Kft. |
| --- |
| Boráros tér. 7/2. 7.e.13 |
| H-1095 Budapest |
| Tel. (36-1) 456 30 90 |
| Fax (36-1) 456 30 99 |

Intervet Hungaria Kft.

Boráros tér. 7/2. 7.e.13

H-1095 Budapest

Tel. (36-1) 456 30 90

Fax (36-1) 456 30 99

Bovilis BVD

As above

As above

As above

As above

As above

Ireland

| Intervet Ireland Ltd |
| --- |
| Magna Drive |
| Magna Business Park |
| Citywest Road |
| Dublin 24 |
| Ireland |
| Tel. (353-1) 463 73 30 |
| Fax (353-1) 451 19 06 |

Intervet Ireland Ltd

Magna Drive

Magna Business Park

Citywest Road

Dublin 24

Ireland

Tel. (353-1) 463 73 30

Fax (353-1) 451 19 06

Bovilis BVD

As above

As above

As above

As above

As above

Italy

| Intervet Italia S.r.l. |
| --- |
| Via W. Tobagi 7 |
| I-20068 Peschiera Borromeo — Milano |
| Tel. (39) 02 51 68 61 |
| Fax (39) 02 51 68 66 87 |

Intervet Italia S.r.l.

Via W. Tobagi 7

I-20068 Peschiera Borromeo — Milano

Tel. (39) 02 51 68 61

Fax (39) 02 51 68 66 87

Bovilis BVD

As above

As above

As above

As above

As above

Latvia

| Intervet Baltic States |
| --- |
| Vasario 16-osios 9-6A |
| LT-Kaunas 3000 |
| Tel. (370) 37 32 16 60 |
| Fax (370) 37 20 12 93 |

Intervet Baltic States

Vasario 16-osios 9-6A

LT-Kaunas 3000

Tel. (370) 37 32 16 60

Fax (370) 37 20 12 93

Bovilis BVD

As above

As above

As above

As above

As above

Lithuania

| Intervet Baltic States |
| --- |
| Vasario 16-osios 9-6A |
| LT-Kaunas 3000 |
| Tel. (370) 37 32 16 60 |
| Fax (370) 37 20 12 93 |

Intervet Baltic States

Vasario 16-osios 9-6A

LT-Kaunas 3000

Tel. (370) 37 32 16 60

Fax (370) 37 20 12 93

Bovilis BVD

As above

As above

As above

As above

As above

Luxembourg

| Intervet Belgium |
| --- |
| Bedrijvenlaan 7 |
| B-2800 Mechelen |
| Tel. (32-15) 43 67 28 |
| Fax (32-15) 43 67 33 |

Intervet Belgium

Bedrijvenlaan 7

B-2800 Mechelen

Tel. (32-15) 43 67 28

Fax (32-15) 43 67 33

Bovilis BVD

As above

As above

As above

As above

As above

The Netherlands

| Intervet International B.V. |
| --- |
| Wim de Körverstraat 35 |
| 5831 AN Boxmeer |
| Nederland |
| Tel. (31-485) 58 76 52 |
| Fax (31-485) 58 76 53 |

Intervet International B.V.

Wim de Körverstraat 35

5831 AN Boxmeer

Nederland

Tel. (31-485) 58 76 52

Fax (31-485) 58 76 53

Bovilis BVD

As above

As above

As above

As above

As above

Poland

| Intervet International BV Sp. z o.o. |
| --- |
| Przedstawicielstwo w Polsce |
| ul. Wybrzeże Gdyńskie 6c |
| PL-01-531 Warszawa |
| Tel. (48-22) 620 11 47 |
| Fax (48-22) 620 29 35 |

Intervet International BV Sp. z o.o.

Przedstawicielstwo w Polsce

ul. Wybrzeże Gdyńskie 6c

PL-01-531 Warszawa

Tel. (48-22) 620 11 47

Fax (48-22) 620 29 35

Bovilis BVD

As above

As above

As above

As above

As above

Portugal

| Intervet Portuguesa Ltd |
| --- |
| Estrada Nacional 249, Km 14,2 |
| P-2725-397 Mem Martins Codes |
| Tel. (351-21) 922 83 00 |
| Fax (351-21) 920 22 31 |

Intervet Portuguesa Ltd

Estrada Nacional 249, Km 14,2

P-2725-397 Mem Martins Codes

Tel. (351-21) 922 83 00

Fax (351-21) 920 22 31

Bovilis BVD

As above

As above

As above

As above

As above

Slovakia

| Representative of Intervet in the Slovak Rep. |
| --- |
| Palárikova 16 |
| SK-040 01 Košice |
| Tel. (421-55) 676 94 05 |
| Fax (421-55) 676 98 73 |

Representative of Intervet in the Slovak Rep.

Palárikova 16

SK-040 01 Košice

Tel. (421-55) 676 94 05

Fax (421-55) 676 98 73

Bovilis BVD

As above

As above

As above

As above

As above

Slovenia

| Intervet International Podružnica |
| --- |
| Križna 10 |
| SLO-1000 Ljubljana |
| Tel. (386-1) 541 75 67 |
| Fax (386-1) 523 35 67 |

Intervet International Podružnica

Križna 10

SLO-1000 Ljubljana

Tel. (386-1) 541 75 67

Fax (386-1) 523 35 67

Bovilis BVD

As above

As above

As above

As above

As above

Spain

| Laboratorios Intervet, S.A. |
| --- |
| Polígono Industrial «El Montalva» |
| Apartado 3006 |
| E-37080 Salamanca |
| Tel. (34-923) 19 03 45 |
| Fax: (34-923) 19 03 47 |

Laboratorios Intervet, S.A.

Polígono Industrial «El Montalva»

Apartado 3006

E-37080 Salamanca

Tel. (34-923) 19 03 45

Fax: (34-923) 19 03 47

Bovilis BVD

As above

As above

As above

As above

As above

UK

| Intervet UK Ltd |
| --- |
| Walton Manor |
| Walton |
| Milton Keynes |
| Buckinghamshire MK7 7AJ |
| United Kingdom |
| Tel. (44-1908) 66 50 50 |
| Fax (44-1908) 66 47 78 |

Intervet UK Ltd

Walton Manor

Walton

Milton Keynes

Buckinghamshire MK7 7AJ

United Kingdom

Tel. (44-1908) 66 50 50

Fax (44-1908) 66 47 78

Bovilis BVD

As above

As above

As above

As above

As above

---

ANNEX III

LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS, ANIMAL SPECIES, FREQUENCY AND ROUTES OF ADMINISTRATION, RECOMMENDED DOSES, WITHDRAWAL PERIODS AND MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES CONCERNED BY THE REFERRAL

| Member State | Marketing Authorisation Holder | Invented name | Pharmaceutical form | Strength | Animal species | Frequency and route of administration | Recommended dose | Withdrawal period
  (meat and milk) |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Czech Republic | Virbac S.A. |
| 1e Avenue |
| 2056 M Lid |
| F-06516 Carros Cedex |

Member State

Marketing Authorisation Holder

Invented name

Pharmaceutical form

Strength

Animal species

Frequency and route of administration

Recommended dose

Withdrawal period

(meat and milk)

Czech Republic

Virbac S.A.

1e Avenue

2056 M Lid

F-06516 Carros Cedex

Suramox 15 % LA

Suspension for injection

150 mg/ml

Cattle, pigs

Two intramuscular injections at 48 hours interval

15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg)

Meat and offal:

| | Cattle: 58 days |
| --- | --- |

Cattle: 58 days

| | Pigs: 35 days |
| --- | --- |

Pigs: 35 days

| | Milk: 2,5 days |
| --- | --- |

Milk: 2,5 days

Spain (1)

| Virbac S.A. |
| --- |
| 1e Avenue |
| 2056 M Lid |
| F-06516 Carros Cedex |

Virbac S.A.

1e Avenue

2056 M Lid

F-06516 Carros Cedex

Stabox 15 % LA

Suspension for injection

150 mg/ml

Cattle, pigs

Two intramuscular injections at 48 hours interval

15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg)

Meat and offal:

| | Cattle: 58 days |
| --- | --- |

Cattle: 58 days

| | Pigs: 35 days |
| --- | --- |

Pigs: 35 days

| | Milk: 2,5 days |
| --- | --- |

Milk: 2,5 days

Italy

| Virbac S.A. |
| --- |
| 1e Avenue |
| 2056 M Lid |
| F-06516 Carros Cedex |

Virbac S.A.

1e Avenue

2056 M Lid

F-06516 Carros Cedex

Stabox 15 % LA

Suspension for injection

150 mg/ml

Cattle, pigs

Two intramuscular injections at 48 hours interval

15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg)

Meat and offal:

| | Cattle: 58 days |
| --- | --- |

Cattle: 58 days

| | Pigs: 35 days |
| --- | --- |

Pigs: 35 days

| | Milk: 2,5 days |
| --- | --- |

Milk: 2,5 days

France (2)

| Virbac S.A. |
| --- |
| 1e Avenue |
| 2056 M Lid |
| F-06516 Carros Cedex |

Virbac S.A.

1e Avenue

2056 M Lid

F-06516 Carros Cedex

Suramox 15 % LA

Suspension for injection

150 mg/ml

Cattle, pigs

Two intramuscular injections at 48 hours interval

15 mg amoxicillin/kg bw (equivalent to 1 ml/10 kg)

Meat and offal:

| | Cattle: 58 days |
| --- | --- |

Cattle: 58 days

| | Pigs: 35 days |
| --- | --- |

Pigs: 35 days

| | Milk: 2,5 days |
| --- | --- |

Milk: 2,5 days

---

(1)  Marketing Authorisation pending.

(2)  Reference Member State for the Mutual recognition Procedure.

---

NOTICES FROM MEMBER STATES

| 27.7.2007 | EN | Official Journal of the European Union | C 174/17 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/17

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 70/2001 on the application of Articles 87 and 88 of the EC Treaty to State aid to small and medium-sized enterprises

(Text with EEA relevance)

(2007/C 174/06)

| Aid No | XS 155/06 |
| --- | --- |
| Member State | Czech Republic |
| Region | Czech Republic, except for NUTS II region Prague |
| Title of aid scheme or name of company receiving individual aid | Joint regional operational programme
  Measure 1.1 — Business support in selected regions
  Sub-measure 4.2.2. — Support for regional and local tourism infrastructure |
| Legal basis | Usnesení vlády č. 102 ze dne 23. ledna 2002
  Usnesení vlády č. 149 ze dne 12. února 2003
  Usnesení vlády č. 79/2003
  Zákon č. 248/2000 Sb., o podpoře regionálního rozvoje, v platném znění
  Zákon č. 215/2004 Sb., o úpravě některých vztahů v oblasti veřejné podpory a o změně zákona o podpoře výzkumu a vývoje, v platném znění
  Nařízení Komise (ES) č. 70/2001 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | EUR 58,182 million (1) |
| Loans guaranteed | — |
| Individual aid | Overall aid amount | — |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes |
| Date of implementation | 1.1.2007 |
| Duration of scheme or individual aid award | Until 31.12.2007 |
| Objective of aid | Aid to SMEs | Yes |
| Economic sectors concerned | All sectors eligible for aid to SMEs | Yes |
| Name and address of the granting authority | Ministerstvo pro místní rozvoj |
| Staroměstské nám. 6 |
| CZ-110 15 Praha 1 |

Aid No

XS 155/06

Member State

Czech Republic

Region

Czech Republic, except for NUTS II region Prague

Title of aid scheme or name of company receiving individual aid

Joint regional operational programme

Measure 1.1 — Business support in selected regions

Sub-measure 4.2.2. — Support for regional and local tourism infrastructure

Legal basis

Usnesení vlády č. 102 ze dne 23. ledna 2002

Usnesení vlády č. 149 ze dne 12. února 2003

Usnesení vlády č. 79/2003

Zákon č. 248/2000 Sb., o podpoře regionálního rozvoje, v platném znění

Zákon č. 215/2004 Sb., o úpravě některých vztahů v oblasti veřejné podpory a o změně zákona o podpoře výzkumu a vývoje, v platném znění

Nařízení Komise (ES) č. 70/2001

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

EUR 58,182 million (1)

Loans guaranteed

—

Individual aid

Overall aid amount

—

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

Date of implementation

1.1.2007

Duration of scheme or individual aid award

Until 31.12.2007

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

All sectors eligible for aid to SMEs

Yes

Name and address of the granting authority

Ministerstvo pro místní rozvoj

Staroměstské nám. 6

CZ-110 15 Praha 1

Large individual aid grants

In conformity with Article 6 of the Regulation

No

None to be granted

| Aid No | XS 172/06 |
| --- | --- |
| Member State | Germany |
| Region | Berlin |
| Title of aid scheme or name of company receiving individual aid | Sulfurcell Solartechnik GmbH |
| Legal basis | Gesetz über die Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ vom 6.10.1969 (BGBl. I, S. 1861), zuletzt geändert durch Art. 102 der Achten Zuständigkeitsanpassungsverordnung vom 25.11.2003 (BGBl. I, S. 2304 ff)
  35. Rahmenplan der Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ (GA) für den Zeitraum 2006 bis 2009, veröffentlicht im Bundesanzeiger Nr. 240 am 20.12.2005 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | — |
| Loans guaranteed | — |
| Individual aid | Overall aid amount:
  (Joint scheme funds: EUR 5 204 100)
  (Investment grants (2): EUR 16 412 660) | EUR 21 616 760 |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes |
| Date of implementation | 28.8.2006 (3) |
| Duration of scheme or individual aid award | Until 31.12.2009 (4) |
| Objective of aid | Aid to SMEs | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| Other manufacturing | Yes |
| Name and address of the granting authority | Investitionsbank Berlin |
| Bundesallee 210 |
| D-10719 Berlin |

Aid No

XS 172/06

Member State

Germany

Region

Berlin

Title of aid scheme or name of company receiving individual aid

Sulfurcell Solartechnik GmbH

Legal basis

Gesetz über die Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ vom 6.10.1969 (BGBl. I, S. 1861), zuletzt geändert durch Art. 102 der Achten Zuständigkeitsanpassungsverordnung vom 25.11.2003 (BGBl. I, S. 2304 ff)

35. Rahmenplan der Gemeinschaftsaufgabe „Verbesserung der regionalen Wirtschaftsstruktur“ (GA) für den Zeitraum 2006 bis 2009, veröffentlicht im Bundesanzeiger Nr. 240 am 20.12.2005

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

—

Loans guaranteed

—

Individual aid

Overall aid amount:

(Joint scheme funds: EUR 5 204 100)

(Investment grants (2): EUR 16 412 660)

EUR 21 616 760

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

Date of implementation

28.8.2006 (3)

Duration of scheme or individual aid award

Until 31.12.2009 (4)

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

Limited to specific sectors

Yes

Other manufacturing

Yes

Name and address of the granting authority

Investitionsbank Berlin

Bundesallee 210

D-10719 Berlin

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 173/06 |
| --- | --- |
| Member State | Finland |
| Region | Aid area I in the development area designated by government decision on the basis of the Regional Development Act No 602/2002 |
| Title of aid scheme or name of company receiving individual aid | Accelerated depreciation for investments made by SMEs in the development area |
| Legal basis | Kehitysalueelle tehtävien investointien korotetuista poistoista annettu laki (1262/1993, muut. 1736/1995, 32/1998, 1215/1998, 964/2000, 901/2001, 914/2003 et 979/2006). |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | Approx. EUR 1 million (5) |
| Loans guaranteed | |
| Individual aid | Overall aid amount | |
| Loans guaranteed | |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes
  Maximum aid intensity: 1 % |
| Date of implementation | From 1.1.2007 |
| Duration of scheme or individual aid award | Until 31.12.2008 |
| Objective of aid | Aid to SMEs | Yes |
| Economic sectors concerned | All sectors eligible for aid to SMEs | Yes |
| Limited to specific sectors | Yes |
| — | Coalmining |

Aid No

XS 173/06

Member State

Finland

Region

Aid area I in the development area designated by government decision on the basis of the Regional Development Act No 602/2002

Title of aid scheme or name of company receiving individual aid

Accelerated depreciation for investments made by SMEs in the development area

Legal basis

Kehitysalueelle tehtävien investointien korotetuista poistoista annettu laki (1262/1993, muut. 1736/1995, 32/1998, 1215/1998, 964/2000, 901/2001, 914/2003 et 979/2006).

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

Approx. EUR 1 million (5)

Loans guaranteed

Individual aid

Overall aid amount

Loans guaranteed

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

Maximum aid intensity: 1 %

Date of implementation

From 1.1.2007

Duration of scheme or individual aid award

Until 31.12.2008

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

All sectors eligible for aid to SMEs

Yes

Limited to specific sectors

Yes

—

Coalmining

No

| — | All manufacturing |
| --- | --- |

—

All manufacturing

or

Steel

No

Shipbuilding

No

Synthetic fibres

No

Motor vehicles

No

Other manufacturing

Yes

| — | All services |
| --- | --- |

—

All services

or

Transport services

No

Financial services

No

Tourism

Yes

Other services

No

Name and address of the granting authority

| Valtiovarainministeriö |
| --- |
| PL 28 |
| FIN-00023 Valtioneuvosto |

Valtiovarainministeriö

PL 28

FIN-00023 Valtioneuvosto

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 175/06 |
| --- | --- |
| Member State | Italy |
| Region | Campania |
| Title of aid scheme or name of company receiving individual aid | Aid scheme for SMEs to build plant for the recovery of materials from waste from specific production categories, to build energy recycling plant for waste not otherwise recoverable and to adapt the technology of existing waste recovery plant (processing of inert waste, motor vehicles, durables, bulky items, quality composting, recovery of plastics) |
| Legal basis | POR Campania 2000-2006
  Complemento di programmazione, misura 1.7, azioni e) e g)
  DGR n. 317 del 4.3.2005 di approvazione dei criteri ed indirizzi, modificata con DGR n. 1545 del 5.10.2006 e DGR n. 1633 del 17.10.2006
  Decreto dirigenziale n. 955 del 14.11.2006 pubblicato sul B.U.R.C. del 20.11.2006 |
| Annual expenditure planned under the scheme | Aid scheme | Annual overall amount | EUR 35,5 million |
| Loans guaranteed | No |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes
  The maximum aid intensity is 35 % nge, plus 15 % gge calculated on the basis of eligible costs relating to land, buildings, construction and related activities, plant, machinery, brand new equipment and intangible assets and 50 % gge of eligible costs relating to planning and studies and support services |
| Date of implementation | From 21.12.2006 |
| Duration of scheme | Until 31.12.2006 |
| Objective of aid | Aid to SMEs | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| Other services | Yes — Waste management |
| Name and address of the granting authority | Regione Campania
  Area Generale di Coordinamento 05
  Settore 02
  Responsabile della Misura 1.7 del POR Campania 2000-2006 |
| Via A. De Gasperi, 28 |
| I-80133 Napoli |
| Tel. (39) 081 796 30 25 |
| E-mail: l.pagnozzi@maildip.regione.campania.it; m.lupacchini@regione.campania.it |

Aid No

XS 175/06

Member State

Italy

Region

Campania

Title of aid scheme or name of company receiving individual aid

Aid scheme for SMEs to build plant for the recovery of materials from waste from specific production categories, to build energy recycling plant for waste not otherwise recoverable and to adapt the technology of existing waste recovery plant (processing of inert waste, motor vehicles, durables, bulky items, quality composting, recovery of plastics)

Legal basis

POR Campania 2000-2006

Complemento di programmazione, misura 1.7, azioni e) e g)

DGR n. 317 del 4.3.2005 di approvazione dei criteri ed indirizzi, modificata con DGR n. 1545 del 5.10.2006 e DGR n. 1633 del 17.10.2006

Decreto dirigenziale n. 955 del 14.11.2006 pubblicato sul B.U.R.C. del 20.11.2006

Annual expenditure planned under the scheme

Aid scheme

Annual overall amount

EUR 35,5 million

Loans guaranteed

No

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

The maximum aid intensity is 35 % nge, plus 15 % gge calculated on the basis of eligible costs relating to land, buildings, construction and related activities, plant, machinery, brand new equipment and intangible assets and 50 % gge of eligible costs relating to planning and studies and support services

Date of implementation

From 21.12.2006

Duration of scheme

Until 31.12.2006

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

Limited to specific sectors

Yes

Other services

Yes — Waste management

Name and address of the granting authority

Regione Campania

Area Generale di Coordinamento 05

Settore 02

Responsabile della Misura 1.7 del POR Campania 2000-2006

Via A. De Gasperi, 28

I-80133 Napoli

Tel. (39) 081 796 30 25

E-mail: l.pagnozzi@maildip.regione.campania.it; m.lupacchini@regione.campania.it

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 182/06 |
| --- | --- |
| Member State | (United Kingdom and) Republic of Ireland |
| Region | 32 Counties of the island of Ireland — Northern Ireland and Republic of Ireland |
| Title of aid scheme or name of company receiving an individual aid | Consultancy Aid for Software Development |
| Legal Basis | British/Irish Agreement Act 1999 Section 2.3 Part 7 of Annex 2 of the act empowers Inter Trade Ireland to invest, lend or grant aid for the purposes of its function |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Total Cost of Scheme:
  2006: GBP 70 000
  2007: GBP 86 000
  The scheme will be implemented on a rolling basis during 2006-2007. Cost of the project is GBP 156 000 over 12 months duration
  Total funding element for the scheme = GBP 6 000. This represents 37 % of the total project cost with the remaining 63 % attributed by the participating enterprise |
| Maximum aid intensity | Up to a maximum of 37 % aid intensity |
| Date of implementation | Proposed scheme to run for 1 year from date of approval
  Individual companies will be eligible for assistance for a maximum of 12 months |
| Duration of scheme or individual aid award | Scheme will run until the end of 2007 |
| Objective of aid | To provide consultancy aid to SMEs in the software sector towards the cost of technology development and promotion of an integrated solution for mobile technology products |
| Economic Sector(s) concerned | Other services |
| Name and address of the granting authority | InterTradeIreland |
| The Old Gasworks Business Park |
| Kilmorey Street |
| Newry |
| Co Down BT34 2DE |
| Northern Ireland |
| United Kingdom |

Aid No

XS 182/06

Member State

(United Kingdom and) Republic of Ireland

Region

32 Counties of the island of Ireland — Northern Ireland and Republic of Ireland

Title of aid scheme or name of company receiving an individual aid

Consultancy Aid for Software Development

Legal Basis

British/Irish Agreement Act 1999 Section 2.3 Part 7 of Annex 2 of the act empowers Inter Trade Ireland to invest, lend or grant aid for the purposes of its function

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Total Cost of Scheme:

2006: GBP 70 000

2007: GBP 86 000

The scheme will be implemented on a rolling basis during 2006-2007. Cost of the project is GBP 156 000 over 12 months duration

Total funding element for the scheme = GBP 6 000. This represents 37 % of the total project cost with the remaining 63 % attributed by the participating enterprise

Maximum aid intensity

Up to a maximum of 37 % aid intensity

Date of implementation

Proposed scheme to run for 1 year from date of approval

Individual companies will be eligible for assistance for a maximum of 12 months

Duration of scheme or individual aid award

Scheme will run until the end of 2007

Objective of aid

To provide consultancy aid to SMEs in the software sector towards the cost of technology development and promotion of an integrated solution for mobile technology products

Economic Sector(s) concerned

Other services

Name and address of the granting authority

InterTradeIreland

The Old Gasworks Business Park

Kilmorey Street

Newry

Co Down BT34 2DE

Northern Ireland

United Kingdom

| Aid No | XS 183/06 |
| --- | --- |
| Member State | Netherlands |
| Region | Provincie Fryslân |
| Title of aid scheme or name of company receiving individual aid | Van der Velden Systeemtechniek B.V. in Drachten |
| Legal basis | Algemene wet bestuursrecht 4.2
  Algemene subsidieverordening SNN |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | — |
| Loans guaranteed | — |
| Individual aid | Overall aid amount | EUR 194 640 |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation
  The total project costs are EUR 486 600. The total eligible costs are EUR 486 600. The aid to be provided by SNN totals EUR 194 640 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %) | Yes |
| Date of implementation | 22.12.2006 |
| Duration of scheme or individual aid award | Until 1.9.2009 |
| Objective of aid | Aid to SMEs
  The objective of the project is to develop a shaftless propulsion system | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| Other manufacturing | Yes, systems technology |
| Name and address of the granting authority | Samenwerkingsverband Noord-Nederland |
| Postbus 779 |
| 9700 AT Groningen |
| Nederland |

Aid No

XS 183/06

Member State

Netherlands

Region

Provincie Fryslân

Title of aid scheme or name of company receiving individual aid

Van der Velden Systeemtechniek B.V. in Drachten

Legal basis

Algemene wet bestuursrecht 4.2

Algemene subsidieverordening SNN

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

—

Loans guaranteed

—

Individual aid

Overall aid amount

EUR 194 640

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

The total project costs are EUR 486 600. The total eligible costs are EUR 486 600. The aid to be provided by SNN totals EUR 194 640 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %)

Yes

Date of implementation

22.12.2006

Duration of scheme or individual aid award

Until 1.9.2009

Objective of aid

Aid to SMEs

The objective of the project is to develop a shaftless propulsion system

Yes

Economic sectors concerned

Limited to specific sectors

Yes

Other manufacturing

Yes, systems technology

Name and address of the granting authority

Samenwerkingsverband Noord-Nederland

Postbus 779

9700 AT Groningen

Nederland

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 184/06 |
| --- | --- |
| Member State | Netherlands |
| Region | Provincie Fryslân |
| Title of aid scheme or name of company receiving individual aid | JB Besturingstechniek B.V. in Oosterwolde |
| Legal basis | Algemene wet bestuursrecht 4.2
  Algemene subsidieverordening SNN |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | — |
| Loans guaranteed | — |
| Individual aid | Overall aid amount | EUR 80 740 |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation
  The total project costs are EUR 201 850. The total eligible costs are EUR 201 850. The aid to be provided by SNN totals EUR 80 740 (aid intensity of 35 % under Article 5a(3)(c) increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %) | Yes |
| Date of implementation | 22.12.2006 |
| Duration of scheme or individual aid award | Until 1.9.2009 |
| Objective of aid | Aid to SMEs
  The objective of the project is to develop a shaftless propulsion system | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| Other manufacturing | Yes, control technology |
| Name and address of the granting authority | Samenwerkingsverband Noord-Nederland |
| Postbus 779 |
| 9700 AT Groningen |
| Nederland |

Aid No

XS 184/06

Member State

Netherlands

Region

Provincie Fryslân

Title of aid scheme or name of company receiving individual aid

JB Besturingstechniek B.V. in Oosterwolde

Legal basis

Algemene wet bestuursrecht 4.2

Algemene subsidieverordening SNN

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

—

Loans guaranteed

—

Individual aid

Overall aid amount

EUR 80 740

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

The total project costs are EUR 201 850. The total eligible costs are EUR 201 850. The aid to be provided by SNN totals EUR 80 740 (aid intensity of 35 % under Article 5a(3)(c) increased by 5 % under Article 5a(4)(a) inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development making a total of 40 %)

Yes

Date of implementation

22.12.2006

Duration of scheme or individual aid award

Until 1.9.2009

Objective of aid

Aid to SMEs

The objective of the project is to develop a shaftless propulsion system

Yes

Economic sectors concerned

Limited to specific sectors

Yes

Other manufacturing

Yes, control technology

Name and address of the granting authority

Samenwerkingsverband Noord-Nederland

Postbus 779

9700 AT Groningen

Nederland

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 185/06 |
| --- | --- |
| Member State | Netherlands |
| Region | Provincie Drenthe |
| Title of aid scheme or name of company receiving individual aid | Combimac B.V. in Emmen |
| Legal basis | Algemene wet bestuursrecht 4.2
  Algemene subsidieverordening SNN |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | — |
| Loans guaranteed | — |
| Individual aid | Overall aid amount | EUR 132 660 |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation
  The total project costs are EUR 331 650. The total eligible costs are EUR 331 650. The aid to be provided by SNN totals EUR 132 660 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a), inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development, making a total of 40 %) | Yes |
| Date of implementation | 22.12.2006 |
| Duration of scheme or individual aid award | Until 1.9.2009 |
| Objective of aid | Aid to SMEs
  The objective of the project is to develop a shaftless propulsion system | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| Other manufacturing | Yes, electric motors |
| Name and address of the granting authority | Samenwerkingsverband Noord-Nederland |
| Postbus 779 |
| 9700 AT Groningen |
| Nederland |

Aid No

XS 185/06

Member State

Netherlands

Region

Provincie Drenthe

Title of aid scheme or name of company receiving individual aid

Combimac B.V. in Emmen

Legal basis

Algemene wet bestuursrecht 4.2

Algemene subsidieverordening SNN

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

—

Loans guaranteed

—

Individual aid

Overall aid amount

EUR 132 660

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

The total project costs are EUR 331 650. The total eligible costs are EUR 331 650. The aid to be provided by SNN totals EUR 132 660 (aid intensity of 35 % under Article 5a(3)(c), increased by 5 % under Article 5a(4)(a), inserted by Commission Regulation (EC) No 364/2004 amending Regulation (EC) No 70/2001 as regards the extension of its scope to include aid for research and development, making a total of 40 %)

Yes

Date of implementation

22.12.2006

Duration of scheme or individual aid award

Until 1.9.2009

Objective of aid

Aid to SMEs

The objective of the project is to develop a shaftless propulsion system

Yes

Economic sectors concerned

Limited to specific sectors

Yes

Other manufacturing

Yes, electric motors

Name and address of the granting authority

Samenwerkingsverband Noord-Nederland

Postbus 779

9700 AT Groningen

Nederland

Large individual aid grants

In conformity with Article 6 of the Regulation

Yes

| Aid No | XS 186/06 |
| --- | --- |
| Member State | Ireland |
| Region | All regions |
| Title of aid scheme or name of company receiving individual aid | SME Development Scheme |
| Legal basis | The Industrial Development Act 1986 as amended
  Údarás na Gaeltachta Act 1979 as amended.
  Shannon Free Airport Development Company Limited Act 1959, as amended. |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Estimated annual overall amount | EUR 40 million |
| Individual aid | Overall aid amount | — |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes |
| Date of implementation | 1.1.2007 |
| Duration of scheme or individual aid award | 2007-2013 subject to revision of SME Regulation (EC) No 70/2001 |
| Objective of aid | Aid to SMEs | Yes |
| Economic sectors concerned | Limited to specific sectors | Yes |
| — | Coalmining |

Aid No

XS 186/06

Member State

Ireland

Region

All regions

Title of aid scheme or name of company receiving individual aid

SME Development Scheme

Legal basis

The Industrial Development Act 1986 as amended

Údarás na Gaeltachta Act 1979 as amended.

Shannon Free Airport Development Company Limited Act 1959, as amended.

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Estimated annual overall amount

EUR 40 million

Individual aid

Overall aid amount

—

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

Date of implementation

1.1.2007

Duration of scheme or individual aid award

2007-2013 subject to revision of SME Regulation (EC) No 70/2001

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

Limited to specific sectors

Yes

—

Coalmining

No

| — | All manufacturing |
| --- | --- |

—

All manufacturing

No

or

Steel

No

Shipbuilding

No

Synthetic fibres

No

Motor vehicles

Yes

Other manufacturing

Yes

| — | All services |
| --- | --- |

—

All services

Yes

or

Transport services

Yes

Financial services

Yes

Other services

Yes

Name and address of the granting authority

| IDA Ireland |
| --- |
| Wilton Park House |
| Wilton Place, Dublin 2 |
| Ireland |

IDA Ireland

Wilton Park House

Wilton Place, Dublin 2

Ireland

| Enterprise Ireland |
| --- |
| Glasnevin |
| Dublin 9 |
| Ireland |

Enterprise Ireland

Glasnevin

Dublin 9

Ireland

| Udaras na Gaeltachta |
| --- |
| Na Forbacha |
| Co na Gaillimhe |

Udaras na Gaeltachta

Na Forbacha

Co na Gaillimhe

| Shannon Free Airport Development Company Ltd |
| --- |
| Shannon Town |
| Co Clare |
| Ireland |

Shannon Free Airport Development Company Ltd

Shannon Town

Co Clare

Ireland

Large individual aid grants

Large individual aid grants as defined in Article 6 of Regulation (EC) No 70/2001 are not exempted from prior notification to the Commission

| Aid No | XS 188/06 |
| --- | --- |
| Member State | Finland |
| Region | Whole country |
| Title of aid scheme or name of company receiving individual aid | Guarantee commission aid for SMEs
  (Takausprovisiotuki pk-yrityksille) |
| Legal basis | Valtion erityisrahoitusyhtiöstä annettu laki (443/1998), valtion erityisrahoitusyhtiön luotto- ja takaustoiminnasta annettu laki (445/1998), Valtioneuvoston sitoumus Finnvera Oyj:lle takausprovisiotuen maksamisesta (1/023/2005) |
| Annual expenditure planned under the scheme or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | Approx. EUR 1,7 million |
| Loans guaranteed | EUR 26 millions |
| Individual aid | Overall aid amount | — |
| Loans guaranteed | — |
| Maximum aid intensity | In conformity with Articles 4(2)-(6) and 5 of the Regulation | Yes |
| Date of implementation | 1.1.2007 |
| Duration of scheme or individual aid award | Until 31.12.2007 |
| Objective of aid | Aid to SMEs | Yes |
| Sector(s) concerned | All sectors eligible for aid to SMEs | Yes |
| Name and address of the granting authority | Finnvera Oyj
  Kotimaan alueellinen rahoitus |
| PL 1010 |
| FIN-00101 Helsinki |

Aid No

XS 188/06

Member State

Finland

Region

Whole country

Title of aid scheme or name of company receiving individual aid

Guarantee commission aid for SMEs

(Takausprovisiotuki pk-yrityksille)

Legal basis

Valtion erityisrahoitusyhtiöstä annettu laki (443/1998), valtion erityisrahoitusyhtiön luotto- ja takaustoiminnasta annettu laki (445/1998), Valtioneuvoston sitoumus Finnvera Oyj:lle takausprovisiotuen maksamisesta (1/023/2005)

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

Approx. EUR 1,7 million

Loans guaranteed

EUR 26 millions

Individual aid

Overall aid amount

—

Loans guaranteed

—

Maximum aid intensity

In conformity with Articles 4(2)-(6) and 5 of the Regulation

Yes

Date of implementation

1.1.2007

Duration of scheme or individual aid award

Until 31.12.2007

Objective of aid

Aid to SMEs

Yes

Sector(s) concerned

All sectors eligible for aid to SMEs

Yes

Name and address of the granting authority

Finnvera Oyj

Kotimaan alueellinen rahoitus

PL 1010

FIN-00101 Helsinki

Large individual aid grants

In conformity with Article 6 of the Regulation

| Aid No | XS 21/07 |
| --- | --- |
| Member State | Italy |
| Region | Sicilia and Valle d'Aosta |
| Title of aid scheme or name of company receiving individual aid | Financial aid for the purchase or lease of new production machines and tools |
| Legal basis | Legge 28.11.1965, n. 1329
  Deliberazione del Comitato Agevolazioni Nazionale del 21.12.2006 |
| Annual expenditure planned or overall amount of individual aid granted to the company | Aid scheme | Annual overall amount | EUR 10 million |
| Loans guaranteed | — |
| Individual aid | Overall aid amount | — |
| Loans guaranteed | — |
| Maximum aid intensity | The scheme is subject to the aid ceilings laid down by Article 4 of the Regulation
  The contribution is calculated on the basis of the amount eligible for aid and is equal to be the difference between:






  — | the net proceeds of the loan at the reference rate, and |

Aid No

XS 21/07

Member State

Italy

Region

Sicilia and Valle d'Aosta

Title of aid scheme or name of company receiving individual aid

Financial aid for the purchase or lease of new production machines and tools

Legal basis

Legge 28.11.1965, n. 1329

Deliberazione del Comitato Agevolazioni Nazionale del 21.12.2006

Annual expenditure planned or overall amount of individual aid granted to the company

Aid scheme

Annual overall amount

EUR 10 million

Loans guaranteed

—

Individual aid

Overall aid amount

—

Loans guaranteed

—

Maximum aid intensity

The scheme is subject to the aid ceilings laid down by Article 4 of the Regulation

The contribution is calculated on the basis of the amount eligible for aid and is equal to be the difference between:

—

the net proceeds of the loan at the reference rate, and

| — | the net proceeds of the loan at the reduced rate, |
| --- | --- |

—

the net proceeds of the loan at the reduced rate,

in force on the date on which the loan is granted

The interest rate for recipient companies is:

| — | zero (no interest payments, i.e. a contribution of 100 % of the reference rate) for enterprises located in Sicily, |
| --- | --- |

—

zero (no interest payments, i.e. a contribution of 100 % of the reference rate) for enterprises located in Sicily,

| — | 50 % of the reference rate for enterprises located in Valle d'Aosta |
| --- | --- |

—

50 % of the reference rate for enterprises located in Valle d'Aosta

Enterprises from either Sicily or Valle d'Aosta investing in the production and marketing of agricultural products sector may not benefit from an aid intensity higher than:

| — | 40 % of eligible costs for enterprises located in non-disadvantaged areas, |
| --- | --- |

—

40 % of eligible costs for enterprises located in non-disadvantaged areas,

| — | 50 % of eligible costs for enterprises located in disadvantaged areas |
| --- | --- |

—

50 % of eligible costs for enterprises located in disadvantaged areas

Date of implementation

1.1.2007

Duration of scheme or individual aid award

Until the expiry date of Regulation (EC) No 70/2001 set by Article 10 of the same Regulation and subsequent amendments and additions

Objective of aid

Aid to SMEs

Yes

Economic sectors concerned

The aid is intended for SMEs, with the following exceptions:

| — | agricultural production, |
| --- | --- |

—

agricultural production,

| — | hunting, |
| --- | --- |

—

hunting,

| — | fisheries, |
| --- | --- |

—

fisheries,

| — | production of dairy products, |
| --- | --- |

—

production of dairy products,

| — | transport |
| --- | --- |

—

transport

The aid is also subject to specific restrictions for the following sectors:

| — | steel, |
| --- | --- |

—

steel,

| — | shipbuilding, |
| --- | --- |

—

shipbuilding,

| — | processing and marketing of agricultural products, |
| --- | --- |

—

processing and marketing of agricultural products,

| — | synthetic fibres |
| --- | --- |

—

synthetic fibres

Name and address of the granting authority

| Ministero dell'Economia e delle finanze |
| --- |
| Dipartimento del Tesoro |
| Via XX Settembre, 97 |
| I-00186 Roma |

Ministero dell'Economia e delle finanze

Dipartimento del Tesoro

Via XX Settembre, 97

I-00186 Roma

---

(1)  The amount relates to 2007 and is made up as follows:

Structural funds: EUR 42,248 million; national public sources: EUR 15,934 million (exchange rate: CZK/EUR 28,465).

(2)  The investments concerned must be made in the period between December 2006 and November 2009. For investments scheduled for before 1 January 2007, the investment grant rates under the Investment Grant Act 2005 were taken into account. For investments from 2007 to 2009, the grant rates under the Investment Grant Act 2007 were used.

(3)  The award decision for the grant from joint scheme funds was issued on 28 August 2006, with a stipulation (ancillary clause to the administrative decision pursuant to Article 36 of the Administrative Procedure Act) that the grant could be paid only after the planned aid was notified under EU rules. On this basis, the actual date of implementation will be the date of approval by the EU.

(4)  The investments must be made in the period between December 2006 and November 2009. The aid is to be paid out in annual instalments in accordance with the progress of the investment project.

(5)  The advantage the companies get from the tax relief comprises the interest benefit from the frontloading of the depreciation, amounting to EUR 0,5 million on the investments over a year.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/27 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/27

---

Amendment by France of public service obligations in respect of scheduled air services between Le Puy-en-Velay and Paris (Orly)

(Text with EEA relevance)

(2007/C 174/07)

| 1. | France has decided to alter, with effect from 14 January 2008, the public service obligation pursuant to Article 4(1)(a) of Council Regulation (EEC) No 2408/92 of 23 July 1992 on access for Community air carriers to intra-Community air routes, in respect of scheduled air services between the airports of Le Puy-en-Velay (Loudes) and Paris (Orly) (1). These obligations replace those published in
  Official Journal of the European Communities C 227 of 1.9.1995 and amended in
  Official Journal of the European Communities C 258 of 15.9.2001. |
| --- | --- |

1.

France has decided to alter, with effect from 14 January 2008, the public service obligation pursuant to Article 4(1)(a) of Council Regulation (EEC) No 2408/92 of 23 July 1992 on access for Community air carriers to intra-Community air routes, in respect of scheduled air services between the airports of Le Puy-en-Velay (Loudes) and Paris (Orly) (1). These obligations replace those published in
  Official Journal of the European Communities C 227 of 1.9.1995 and amended in
  Official Journal of the European Communities C 258 of 15.9.2001.

| 2. | The new public service obligation is as follows:
  Minimum frequency
  The minimum level of service provided must be two return trips a day, morning and evening, from Monday to Friday, excluding public holidays, 220 days a year.
  The service must be non-stop between Le Puy-en-Velay (Loudes) and Paris (Orly).
  Type of aircraft used
  The service must be operated with a pressurised aircraft having a seating capacity of at least 19.
  Timetables
  During the week, the timetables must allow passengers to make a round trip within the day and to spend at least seven hours and thirty minutes in Le Puy-en-Velay and eight hours in Paris.
  Fares
  The maximum cost of a one-way ticket is EUR 223 (as at January 2008). This fare excludes per capita taxes and duties other than the value added tax levied by the State, local authorities and airport authorities, and identified as such on the air ticket. It will be revised each year on the basis of the index of the cost of transport services published by the National Institute for statistics and economic studies (Institut national de la statistique et des études économiques).
  If an abnormal and unforeseeable increase in the cost factors affecting the operation of the routes takes place for which the carriers are not responsible, this maximum fare may be raised in proportion to the increase. It will be notified to the carriers operating the services and will apply within an appropriate period after being communicated to the European Commission for publication in the Official Journal of the European Union.
  Continuity of service
  Except in cases of force majeure, the number of flights cancelled for reasons directly attributable to the carrier must not exceed 3 % of the number of flights scheduled in any year. The carrier must give six months' notice before discontinuing the services.
  Community carriers are hereby informed that the operation of air services without regard to the abovementioned public service obligations may result in administrative and/or criminal penalties. |
| --- | --- |

2.

The new public service obligation is as follows:

Minimum frequency

The minimum level of service provided must be two return trips a day, morning and evening, from Monday to Friday, excluding public holidays, 220 days a year.

The service must be non-stop between Le Puy-en-Velay (Loudes) and Paris (Orly).

Type of aircraft used

The service must be operated with a pressurised aircraft having a seating capacity of at least 19.

Timetables

During the week, the timetables must allow passengers to make a round trip within the day and to spend at least seven hours and thirty minutes in Le Puy-en-Velay and eight hours in Paris.

Fares

The maximum cost of a one-way ticket is EUR 223 (as at January 2008). This fare excludes per capita taxes and duties other than the value added tax levied by the State, local authorities and airport authorities, and identified as such on the air ticket. It will be revised each year on the basis of the index of the cost of transport services published by the National Institute for statistics and economic studies (Institut national de la statistique et des études économiques).

If an abnormal and unforeseeable increase in the cost factors affecting the operation of the routes takes place for which the carriers are not responsible, this maximum fare may be raised in proportion to the increase. It will be notified to the carriers operating the services and will apply within an appropriate period after being communicated to the European Commission for publication in the Official Journal of the European Union.

Continuity of service

Except in cases of force majeure, the number of flights cancelled for reasons directly attributable to the carrier must not exceed 3 % of the number of flights scheduled in any year. The carrier must give six months' notice before discontinuing the services.

Community carriers are hereby informed that the operation of air services without regard to the abovementioned public service obligations may result in administrative and/or criminal penalties.

| 3. | Slots are currently reserved at Paris (Orly) airport for the scheduled Paris (Orly) — Le Puy-en-Velay service pursuant to Article 9 of Council Regulation (EEC) No 95/93 of 18 January 1993 on common rules for the allocation of slots at Community airports (2). Carriers interested in this route can obtain information on the slots from the Paris airports coordinator. |
| --- | --- |

3.

Slots are currently reserved at Paris (Orly) airport for the scheduled Paris (Orly) — Le Puy-en-Velay service pursuant to Article 9 of Council Regulation (EEC) No 95/93 of 18 January 1993 on common rules for the allocation of slots at Community airports (2). Carriers interested in this route can obtain information on the slots from the Paris airports coordinator.

---

(1)  OJ L 240, 24.9.1992, p. 8.

(2)  OJ L 14, 22.1.1993, p. 1. Regulation as last amended by Regulation (EC) No 793/2004 of the European Parliament and of the Council (OJ L 138, 30.4.2004, p. 50).

---

V Announcements

ADMINISTRATIVE PROCEDURES

European Food Safety Authority

| 27.7.2007 | EN | Official Journal of the European Union | C 174/28 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/28

---

Call for expressions of interest for the position of member of the Management Board of the European Food Safety Authority

(2007/C 174/08)

Applications are invited for the positions of 7 out of 14 members of the Management Board of the European Food Safety Authority established by Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety (1). The Authority is located in Parma, Italy.

The European Food Safety Authority

The European Food Safety Authority (EFSA) is the keystone of European Union risk assessment regarding food and feed safety. The Authority was established to provide scientific advice and support for Community legislation and policies in all fields that may have a direct or indirect impact on food and feed safety, as well as closely associated questions in the field of animal health and welfare and plant health. It provides independent information on these matters and communicates on risks. Its mission also includes provision of scientific advice on nutrition, particularly in relation to Community legislation, and GMOs, including also new food technologies. The Authority has rapidly earned a reputation with its stakeholders as the accepted point of reference by virtue of its independence, the scientific quality of its opinions and public information, the transparency of its procedures and its diligence in performing its tasks. In addition to having its own specialist personnel, the Authority is supported by networks of competent organisations in the EU.

Legal background

In accordance with Art. 25 of the above-mentioned Regulation, ‘the members of the Board shall be appointed in such a way as to secure the highest standards of competence, a broad range of relevant expertise and, consistent with these, the broadest possible geographic distribution within the Union’. In addition, four of the members of the Management Board ‘shall have their background in organisations representing consumers and other interests in the food chain’.

Furthermore, Recital 40 of the aforementioned Regulation stipulates that ‘Cooperation with Member States is also indispensable’ and Recital 41 states that ‘the Management Board should be appointed in such a way as to secure the highest standard of competence, a broad range of relevant expertise, for instance in management and in public administration, and the broadest possible geographic distribution within the Union. This should be facilitated by a rotation of the different countries of origin of the members of the Management Board without any post being reserved for nationals of any specific Member State.’

Role and operation of the Management Board

The responsibilities of the Management Board include, in particular:

| — | general monitoring of the work of the Authority to ensure that it carries out its mission and performs the tasks assigned to it in accordance with its mandate and within a culture of independence and transparency, |
| --- | --- |

—

general monitoring of the work of the Authority to ensure that it carries out its mission and performs the tasks assigned to it in accordance with its mandate and within a culture of independence and transparency,

| — | the appointment of the Executive Director on the basis of the list drawn up by the Commission, and, if necessary, his or her dismissal, |
| --- | --- |

—

the appointment of the Executive Director on the basis of the list drawn up by the Commission, and, if necessary, his or her dismissal,

| — | the appointment of the members of the Scientific Committee and Panels which are responsible for providing the scientific opinions of the Authority, |
| --- | --- |

—

the appointment of the members of the Scientific Committee and Panels which are responsible for providing the scientific opinions of the Authority,

| — | the adoption of annual and multi-annual programmes of work of the Authority and the general report of annual activities, |
| --- | --- |

—

the adoption of annual and multi-annual programmes of work of the Authority and the general report of annual activities,

| — | the adoption of the Authority's internal rules and financial regulation. |
| --- | --- |

—

the adoption of the Authority's internal rules and financial regulation.

The Board operates by formal meetings, private sessions, informal contacts between members and correspondence. EFSA papers, Board correspondence and private or informal sessions are held in English. Formal sessions include interpretation where Members need this. The Board meets four to six times per year, predominantly in Parma but also in other EU locations where appropriate.

Composition of the Management Board

The Management Board is composed of 14 members appointed by the Council in consultation with the European Parliament, plus a representative of the Commission. The 14 members of the Management Board have been appointed on 15 July 2002 by Council Decision (2), the term of office for 7 of whom expired on 30 June 2006. They were replaced or had their mandate renewed until 30 June 2010 by Council Decision 2006/478/EC (3). The term of office of the other seven members of the Management Board will end on 30 June 2008. Three of them were appointed as having a background in organisations representing consumers and other interests in the food chain.

Current membership of the Board can be seen on EFSA's website:

http://www.efsa.europa.eu/en/mboard/members.html

This publication concerns applications for the positions of those seven members of the first Management Board whose term expires on 30 June 2008.

Qualifications for the position

The members of the Management Board need the competence and collective expertise necessary to guide the Authority on matters relating to its mission, particularly to ensure:

| 1. | efficient delivery of scientific advice and support to meet the European Community's needs in relation to its legislation and policies and its work in the public interest; |
| --- | --- |

1.

efficient delivery of scientific advice and support to meet the European Community's needs in relation to its legislation and policies and its work in the public interest;

| 2. | application of sound principles of management and public administration; |
| --- | --- |

2.

application of sound principles of management and public administration;

| 3. | its functioning is guided by the principles of integrity, independence, transparency, ethical practices and high scientific quality while maintaining the indispensable cooperation with Member States; |
| --- | --- |

3.

its functioning is guided by the principles of integrity, independence, transparency, ethical practices and high scientific quality while maintaining the indispensable cooperation with Member States;

| 4. | communication and information to the public on scientific issues; |
| --- | --- |

4.

communication and information to the public on scientific issues;

| 5. | the creation and maintenance of a reputation for a high level of excellence, objectivity and reliability with its stakeholders; |
| --- | --- |

5.

the creation and maintenance of a reputation for a high level of excellence, objectivity and reliability with its stakeholders;

| 6. | promotion of the necessary coherence between risk assessment, risk management and risk communication functions. |
| --- | --- |

6.

promotion of the necessary coherence between risk assessment, risk management and risk communication functions.

Candidates will need to demonstrate that they can contribute effectively to one or more of the areas listed above. They must have had at least 15 years of experience in one or more of these areas, including at least 5 years at a senior level. Candidates shall have at least five years of experience gained from work in connection with food and feed safety or other areas related to the Authority's mission, notably in the field of animal health and welfare, protection of the environment (4), plant health and nutrition. On the basis of their experience, candidates shall demonstrate their ability to operate in a multilingual, multicultural and multidisciplinary environment. Candidates will be selected on the basis of comparative merits in relation to the above-mentioned criteria and, consistent with these, of the broadest possible geographic distribution within the Union.

Independence and declarations of commitment and interest

Board members will be nominated in a personal capacity. They will be required to make a declaration of commitment to act independently in the public interest and to make a declaration in relation to interests which might be considered prejudicial to their independence. Therefore, in line with the principle of independence in the functioning of the Board, applicants are asked to indicate in the application form any direct or indirect relationship they consider to be relevant to the mission of the Authority.

Participation in the Board meetings

Members will need to make a high level of commitment to participate in the meetings of the Management Board. They are asked to indicate in the application form their availability to actively participate in the Management Board. It is estimated that the Management Board will meet four to six times per year. Members of the Board are not remunerated, but will be reimbursed for their normal travel and subsistence costs. They will also receive indemnities for each day spent at meetings in accordance with Art. 15 of the Rules of Procedure of the Management Board of EFSA, which states that ‘members of the Management Board other than the Commission representative and those employed by a national public body or institution will receive a daily indemnity of EUR 300 for each meeting of the Board for which he/she is present’.

Members of the Management Board having a background in organisations representing consumers and other interests in the food chain

Candidates are asked to indicate if their application could be considered as an expression of interest in the context of such Board Members and, if so, to provide details of their background in organisations representing consumers and other interests in the food chain.

Appointment and term of mandate

With the exception of the Commission representative, who is appointed by the Commission, members of the Management Board are appointed by the Council, in consultation with the European Parliament, from the list drawn up by the Commission on the basis of this call for expressions of interest. The term of office shall be four years and can be renewed once. Applicants should note that the Commission's list will be made public. Individuals on the Commission's list who are not appointed may be invited to constitute a reserve list to be used in the event of the need to replace members who are unable to complete their mandate.

Nationality

In this call, the Commission will seek to establish a short-list that, consistent with appointments securing the highest standards of competence and a broad range of expertise, will enable the appointments also to meet the objective of ‘the broadest possible geographical distribution’ to be facilitated by ‘a rotation of the different countries of origin of the Members’. It should be noted that the members whose terms of office ends on 30 June 2010 already include nationals of Belgium, Denmark, France, Greece, Hungary, Netherlands, Sweden, and that outgoing members (who may re-apply) include nationals of Finland, Germany, Ireland, Italy, Portugal, Slovenia and United Kingdom. To date, the Board has not included nationals of Bulgaria, Cyprus, Czech Republic, Estonia, Latvia, Lithuania, Luxembourg, Malta, Poland, Romania, and Slovakia. This Call is open to nationals of any EU Member State. Applicants must be nationals of an EU Member State.

Equal Opportunities

The European Union takes great care to avoid any form of discrimination and actively encourages applications from women.

APPLICATION PROCEDURE AND CLOSING DATE

Applications shall comply with the requirements set out below; otherwise they will not be taken into consideration:

| 1. | Interested persons must use the attached form, which can also be downloaded from the Health and Consumer Protection Directorate-General's website at:
  http://ec.europa.eu/food/efsa/efsa_management_board_en.htm |
| --- | --- |

1.

Interested persons must use the attached form, which can also be downloaded from the Health and Consumer Protection Directorate-General's website at:

http://ec.europa.eu/food/efsa/efsa_management_board_en.htm

| 2. | The application must be complete. It must include the application, as referred to in paragraph 3 below in one original printed version and three copies. |
| --- | --- |

2.

The application must be complete. It must include the application, as referred to in paragraph 3 below in one original printed version and three copies.

| 3. | The application must include:






  (a) | a letter of motivation (signed); |
| --- | --- | --- |

3.

The application must include:

(a)

a letter of motivation (signed);

| (b) | a completed application form (signed); |
| --- | --- |

(b)

a completed application form (signed);

| (c) | a CV of minimum 1,5 pages and maximum 3 pages. |
| --- | --- |

(c)

a CV of minimum 1,5 pages and maximum 3 pages.

| 4. | The letter of motivation, the application form, the CV, and the supporting documents have to be written in an official language of the European Community. It would, however, be desirable to include a summary of experience and other pertinent information in English in order to facilitate the selection procedure. All applications will be treated as confidential. Supporting documents must be submitted at a later stage, if requested. |
| --- | --- |

4.

The letter of motivation, the application form, the CV, and the supporting documents have to be written in an official language of the European Community. It would, however, be desirable to include a summary of experience and other pertinent information in English in order to facilitate the selection procedure. All applications will be treated as confidential. Supporting documents must be submitted at a later stage, if requested.

| 5. | The final deadline for submission of applications is 24.9.2007. |
| --- | --- |

5.

The final deadline for submission of applications is 24.9.2007.

| 6. | The complete application must be sent:






  (a) | either by post or by courier service not later than 24.9.2007, in which case the evidence of the date of dispatch shall be constituted by the postmark or the date of the deposit slip, to the following address:





  European Commission |
| --- | --- | --- |
| Health and Consumer Protection Directorate-General |
| Unit 03 — Science and Stakeholder relations |
| For the attention of Mr R. Vanhoorde (Application for the Management Board) |
| Office F-101 04/168 |
| B-1049 Brussels |

6.

The complete application must be sent:

(a)

either by post or by courier service not later than 24.9.2007, in which case the evidence of the date of dispatch shall be constituted by the postmark or the date of the deposit slip, to the following address:

European Commission

Health and Consumer Protection Directorate-General

Unit 03 — Science and Stakeholder relations

For the attention of Mr R. Vanhoorde (Application for the Management Board)

Office F-101 04/168

B-1049 Brussels

| (b) | or delivered by hand to the following address:





  European Commission |
| --- | --- |
| Health and Consumer Protection Directorate-General |
| Unit 03 — Science and stakeholder relations |
| For the attention of Mr R. Vanhoorde (Application for the Management Board) |
| Avenue du Bourget 1 |
| B-1140 Brussels (Evere) |

(b)

or delivered by hand to the following address:

European Commission

Health and Consumer Protection Directorate-General

Unit 03 — Science and stakeholder relations

For the attention of Mr R. Vanhoorde (Application for the Management Board)

Avenue du Bourget 1

B-1140 Brussels (Evere)

not later than 16.00 on 24.9.2007. In this case, a receipt must be obtained as proof of submission, signed and dated by the official in the Commission's central mail department who took delivery. The department is open from 8.00 to 17.00 Monday to Thursday, and from 8.00 to 16.00 on Fridays. It is closed on Saturdays, Sundays and Commission holidays.

Neither the applications sent by electronic mail or fax, nor those sent directly to the European Food Safety Authority will be accepted.

| 7. | In submitting an application, applicants accept the procedures and conditions as described in this call and in the documents to which it refers. In compiling their application, applicants may under no circumstances refer to any documents of any type submitted in prior applications (example: photocopies of previous applications will not be accepted). Any misrepresentation in supplying the required information may lead to the exclusion from the present Call. |
| --- | --- |

7.

In submitting an application, applicants accept the procedures and conditions as described in this call and in the documents to which it refers. In compiling their application, applicants may under no circumstances refer to any documents of any type submitted in prior applications (example: photocopies of previous applications will not be accepted). Any misrepresentation in supplying the required information may lead to the exclusion from the present Call.

Image

Image

Image

Image

Image

---

(1)  OJ L 31, 1.2.2002, p. 1.

(2)  OJ C 179, 27.7.2002, p. 9.

(3)  OJ L 189, 12.7.2006, p. 7.

(4)  Ecology, protection of the biodiversity.

---

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY

Commission

| 27.7.2007 | EN | Official Journal of the European Union | C 174/37 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/37

---

Prior notification of a concentration

(Case COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N)

Candidate case for simplified procedure

(Text with EEA relevance)

(2007/C 174/09)

| 1. | On 18 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1), by which Sumitomo Chemical Company (‘Sumitomo’, Japan), Itochu Corporation (‘Itochu’, Japan) and Toyo Ink Mfg. (‘Toyo’, Japan) acquire, within the meaning of Article 3(1)(b) of the Council Regulation, joint control of AK&N UK Ltd (‘AK&N’, UK) by way of purchase of shares. |
| --- | --- |

1.

On 18 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1), by which Sumitomo Chemical Company (‘Sumitomo’, Japan), Itochu Corporation (‘Itochu’, Japan) and Toyo Ink Mfg. (‘Toyo’, Japan) acquire, within the meaning of Article 3(1)(b) of the Council Regulation, joint control of AK&N UK Ltd (‘AK&N’, UK) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Sumitomo: production of chemicals, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Sumitomo: production of chemicals,

| — | for Itochu: general trading company, |
| --- | --- |

—

for Itochu: general trading company,

| — | for Toyo: printing inks and equipment, chemicals, resins, |
| --- | --- |

—

for Toyo: printing inks and equipment, chemicals, resins,

| — | for AK&N: manufacture and marketing of thermoplastic compound materials. |
| --- | --- |

—

for AK&N: manufacture and marketing of thermoplastic compound materials.

| 3. | On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified concentration could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4769 — Sumitomo/Itochu/Toyo/AK&N to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  OJ C 56, 5.3.2005, p. 32.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/38 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/38

---

Prior notification of a concentration

(Case COMP/M.4830 — CVC/Samsonite)

Candidate case for simplified procedure

(Text with EEA relevance)

(2007/C 174/10)

| 1. | On 17 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Group Sarl (‘CVC’, Luxembourg) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Samsonite Corporation (‘Samsonite’, USA) by way of purchase of shares. |
| --- | --- |

1.

On 17 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking CVC Capital Partners Group Sarl (‘CVC’, Luxembourg) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Samsonite Corporation (‘Samsonite’, USA) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for CVC: private equity fund, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for CVC: private equity fund,

| — | for Samsonite: manufacture and sale of luggage and other travelling items. |
| --- | --- |

—

for Samsonite: manufacture and sale of luggage and other travelling items.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4830 — CVC/Samsonite, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4830 — CVC/Samsonite, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

(2)  OJ C 56, 5.3.2005, p. 32.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/39 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/39

---

Prior notification of a concentration

(Case COMP/M.4744 — INEOS/Borealis)

(Text with EEA relevance)

(2007/C 174/11)

| 1. | On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Borealis AS (‘Borealis’, Norway) belonging to the Borealis Group by way of purchase of shares. |
| --- | --- |

1.

On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Borealis AS (‘Borealis’, Norway) belonging to the Borealis Group by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for INEOS: production, distribution, sales and marketing of intermediate and specialty chemicals, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for INEOS: production, distribution, sales and marketing of intermediate and specialty chemicals,

| — | for Borealis: production of polyolefins. |
| --- | --- |

—

for Borealis: production of polyolefins.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4744 — INEOS/Borealis, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4744 — INEOS/Borealis, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 27.7.2007 | EN | Official Journal of the European Union | C 174/40 |
| --- | --- | --- | --- |

27.7.2007

EN

Official Journal of the European Union

C 174/40

---

Prior notification of a concentration

(Case COMP/M.4734 — INEOS/Kerling)

(Text with EEA relevance)

(2007/C 174/12)

| 1. | On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Kerling ASA (‘Kerling’, Norway) belonging to the Norsk Hydro Group by way of purchase of shares. |
| --- | --- |

1.

On 19 July 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking INEOS Group Limited (‘INEOS’, United Kingdom) belonging to the INEOS Group acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Kerling ASA (‘Kerling’, Norway) belonging to the Norsk Hydro Group by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for INEOS: production, distribution, sales and marketing of intermediate and specialty chemicals, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for INEOS: production, distribution, sales and marketing of intermediate and specialty chemicals,

| — | for Kerling: production and sale of PVC and caustic soda. |
| --- | --- |

—

for Kerling: production and sale of PVC and caustic soda.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4734 — INEOS/Kerling, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4734 — INEOS/Kerling, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---